KPIs & Operating Metrics(New)
Breakdown Of AssetsDiaggregated Revenue AnnualDiaggregated Revenue Mix Annual %Disaggregated RevenueDisaggregated Revenue Mix %Employee StatisticsNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX BreakdownProperty And Equipment, NetRevenueRevenue AnnualRevenue From PayorsRevenue From Payors AnnualRevenue Mix From Payors %Revenue Mix From Payors Annual %Test Reports DeliveredTest Reports Delivered BreakdownTest Reports Delivered Total
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Revenue: 2018-2024

Historic Revenue for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $332.1 million.

  • Castle Biosciences' Revenue fell 3.19% to $83.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $343.5 million, marking a year-over-year increase of 10.15%. This contributed to the annual value of $332.1 million for FY2024, which is 51.09% up from last year.
  • Per Castle Biosciences' latest filing, its Revenue stood at $332.1 million for FY2024, which was up 51.09% from $219.8 million recorded in FY2023.
  • In the past 5 years, Castle Biosciences' Revenue registered a high of $332.1 million during FY2024, and its lowest value of $62.6 million during FY2020.
  • In the last 3 years, Castle Biosciences' Revenue had a median value of $219.8 million in 2023 and averaged $229.6 million.
  • Data for Castle Biosciences' Revenue shows a peak YoY surged of 60.38% (in 2023) over the last 5 years.
  • Over the past 5 years, Castle Biosciences' Revenue (Yearly) stood at $62.6 million in 2020, then soared by 50.18% to $94.1 million in 2021, then soared by 45.65% to $137.0 million in 2022, then surged by 60.38% to $219.8 million in 2023, then skyrocketed by 51.09% to $332.1 million in 2024.